-
Evaluating EU-HTA PICO Exercise Outcomes: Duration of Response and Time to Response in Hepatocellular Carcinoma Using Randomization-Preserving Methods with IMbrave150 Data
Sep 9, 2025, 16:22 PM -
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
Real-World Outcomes From a Pharmacy-Based Awareness and Screening Campaign for HF and CKD: Insights From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM -
Effectiveness of Subcutaneous Natalizumab in Multiple Sclerosis: Real-World Evidence From a Finnish Registry Study
Sep 9, 2025, 16:22 PM -
Impact of the Societal Perspective on HTA Decision Making in Rare Diseases
Sep 9, 2025, 16:22 PM -
How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?
Sep 9, 2025, 16:22 PM -
Navigating Clinical Trial Design Under the EU Health Technology Assessment Regulation
Sep 9, 2025, 16:22 PM -
Mind the Gap: Exploring Variation in Guidelines for Indirect Treatment Comparison (ITC) Across Europe
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on the Resource Impact of Subcutaneous vs. Intravenous Atezolizumab in an NHS Cancer Center
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Sep 9, 2025, 16:22 PM -
Trends in Hospitalizations and Amputations in Diabetic Foot Ulcers (DFUs) in Germany 2019 to 2024
Sep 9, 2025, 16:22 PM -
From Methods to Decisions: A Transparent Framework for Population-Adjusted Treatment Comparisons
Sep 9, 2025, 16:22 PM -
Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?
Sep 9, 2025, 16:22 PM -
Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies
Sep 9, 2025, 16:22 PM -
Herpes Zoster Hospitalization Rates in Germany: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
Assessing the Potential Impact of NICE’s Updated HST Routing Criteria on Ultraorphan Drugs
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices
Sep 9, 2025, 16:22 PM -
A Data-Driven Framework for Rare Disease Protocol Design: Integrating Real-World Evidence, Patient Perspectives, and Regulatory Guidance
Sep 9, 2025, 16:22 PM -
Epidemiology and Outcomes in a Linked Cohort of Cancer Pathology and Electronic Medical Records From the PHARMO Data Network
Sep 9, 2025, 16:22 PM -
The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM
